Pfizer to Pay 
12.5 Dividend
Mumbai: Pfizer said it has registered a net profit of 
48.10 crore in the fourth quarter ended March 31, 2012, against 63.14 crore in the year-ago period.
Sales stood at 251.73 crore against 293.17 crore, Pfizer said in its communication to the BSE.
For the year ended March 31, 2012, it posted a net profit of 184.61 crore against 226.34 crore during the 16-months ended March 31, 2011. Sales stood at 1,017.30 crore against 1,169.56 crore. The board has recommended a dividend of 12.5 per share for the year ended March 31, 2012.
The company said that its pharmaceutical division reported revenue of 216.34 crore in the quarter under review against 251.17 crore.
Slump sale
The company said it has changed its accounting year from December-November to April-March with effect from December 2009.
The business operation of animal health division was transferred to the wholly-owned subsidiary on April 2, 2012, by way of slump sale for a consideration of 440 crore, subject to adjustment for working capital, the company said.
Meanwhile, the company said that Bomi M. Gagrat, non-Executive Director of the company, had resigned from the board on Monday. It has appointed Uday Khanna, Sunil Madhok and Vivek Dhariwal as additional directors, it said.
Source: PTI
48.10 crore in the fourth quarter ended March 31, 2012, against 63.14 crore in the year-ago period.
Sales stood at 251.73 crore against 293.17 crore, Pfizer said in its communication to the BSE.
For the year ended March 31, 2012, it posted a net profit of 184.61 crore against 226.34 crore during the 16-months ended March 31, 2011. Sales stood at 1,017.30 crore against 1,169.56 crore. The board has recommended a dividend of 12.5 per share for the year ended March 31, 2012.
The company said that its pharmaceutical division reported revenue of 216.34 crore in the quarter under review against 251.17 crore.
Slump sale
The company said it has changed its accounting year from December-November to April-March with effect from December 2009.
The business operation of animal health division was transferred to the wholly-owned subsidiary on April 2, 2012, by way of slump sale for a consideration of 440 crore, subject to adjustment for working capital, the company said.
Meanwhile, the company said that Bomi M. Gagrat, non-Executive Director of the company, had resigned from the board on Monday. It has appointed Uday Khanna, Sunil Madhok and Vivek Dhariwal as additional directors, it said.
